Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography

Journal of Ultrasound in Medicine

Volumn 26, Issue 11, 2007, Pages 1545-1556

  Murphy Lavallee, Jessica ^a,c   Jang, Hyun Jung ^a   Tae, Kyoung Kim ^a   Burns, Peter N ^a,b   Wilson, Stephanie R ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d FOOTHILLS HOSPITAL   (Canada)

Author keywords

Contrast agent; Liver neoplasms; Metastases; Microbubbles; Ultrasonography

Indexed keywords

BIOLOGICAL ORGANS; IMAGE ANALYSIS; MAGNETIC RESONANCE IMAGING; MEDICAL PROBLEMS; RADIOLOGY; ULTRASONOGRAPHY;

CONTRAST AGENT; LIVER NEOPLASMS; METASTASES; MICROBUBBLES;

BLOOD VESSELS;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUOROCARBON; PERFLUTREN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; INFORMED CONSENT; KAPPA STATISTICS; LIVER METASTASIS; MALE; MEDICAL RECORD REVIEW; MEDICAL RESEARCH; MELANOMA; NEUROENDOCRINE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; RADIOLOGIST; RETROSPECTIVE STUDY; TERATOLOGY; VASCULARIZATION; ECHOGRAPHY; IMAGE ENHANCEMENT; LIVER TUMOR; METASTASIS; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; CONTRAST MEDIA; FEMALE; FLUOROCARBONS; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MALE; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY;

EID: 36749003263     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2007.26.11.1545     Document Type: Article

References (24)

1. Hohmann J, Albrecht T, Oldenberg A, Wolf K-K. Liver metastases in cancer: detection with contrast-enhanced ultrasonography. Abdom Imaging 2004; 29:669-681.
2. Blomley MJK, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999; 210:409-416.
3. Albrecht T, Oldenburg A, Hohmann J, et al. Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur Radiol 2003; 13(suppl 3):N79-N86.
4. Kim TK, Choi BI, Hong HS, Choi BY, Han JK. Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SH U 508A: preliminary study. Ultrasound Med Biol 2000; 26:1439-1444.
5. Quaia E, Bertolotto M, Forgacs B, Rimondini A, Locatelli M, Mucelli RP. Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol 2003; 13:475-483.
6. Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR Am J Roentgenol 2006; 186:1401-1412.
7. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics 2004; 24:921-935.
8. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002; 222:95-102.
9. Nicolau C, Vilana R, Catala V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions. AJR Am J Roentgenol 2006; 186:158-167.
10. Leen E, Ceccotti P, Kalogeropoulou C, Angerson WJ, Moug SJ, Horgan PG. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR Am J Roentgenol 2006; 186:1551-1559.
11. Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med 2004; 25:249-256.
12. Matsumura M, Bevan P, Lindvere L, et al. Do different factors determine the in vivo and in vitro longevity of perfluorocarbon contrast agents? Paper presented at: Ninth European Symposium on Ultrasound Contrast Imaging; January 22-23, 2004; Rotterdam, the Netherlands.
13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.
14. Kanematsu M, Kondo H, Goshima S, et al. Imaging liver metastases: review and update. Eur J Radiol 2006; 58:217-228.
15. Jang HJ, Kim TK, Wilson SR. Imaging of malignant liver masses: characterization and detection. Ultrasound Q 2006; 22:19-29.
16. Chen MH, Dai Y, Yan K, et al. The role of contrast-enhanced ultrasound on the diagnosis of small hepatocellular carcinoma (
17. Nicolau C, Català V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14:1092-1099.
18. Krix M, Kiessling F, Essing M, et al. Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography. Invest Radiol 2004; 39:216-222.
19. Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004; 53:401-105.
20. Gonda T, Ishida H, Yoshinga K, Sugihara K. Microvasculature of small liver metastases in rats. J Surg Res 2000; 94:43-48.
21. Kan Z, Ivancev K, Lunderquist A, et al. In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology 1993; 187:621-626.
22. Ueda T, Oda T, Kinoshita T, et al. Neovascularization in pancreatic ductal adenocarcinoma: microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas. Oncol Rep 2002; 9:239-245.
23. Cosgrove DO. Angiogenesis imaging: ultrasound. Br J Radiol 2003; 76(special issue 1):S43-S49.
24. Lassau N, Lamuraglia M, Chami L, et al. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. AJR Am J Roentgenol 2006; 187:1267-1273.